HROW Stock Summary and Trading Ideas (Harrow | NASDAQ:HROW)

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.

Harrow trades on the NASDAQ stock market under the symbol HROW.

As of November 15, 2024, HROW stock price declined to $39.01 with 1,274,288 million shares trading.

HROW has a beta of 2.07, meaning it tends to be more sensitive to market movements. HROW has a correlation of 0.08 to the broad based SPY ETF.

HROW has a market cap of $1.38 billion. This is considered a Small Cap stock.

Last quarter Harrow reported $49 million in Revenue and -$.05 earnings per share. This fell short of revenue expectation by $-4 million and met earnings estimates .

In the last 3 years, HROW traded as high as $59.23 and as low as $5.40.

The top ETF exchange traded funds that HROW belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.

HROW has outperformed the market in the last year with a return of +375.2%, while the SPY ETF gained +32.1%. However, in the most recent history, HROW shares have underperformed the stock market with its stock returning +5.3% in the last 3 month period and -13.4% for the last 2 week period, while SPY has returned +8.0% and +3.0%, respectively.

HROW support price is $41.17 and resistance is $44.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HROW shares will trade within this expected range on the day.